no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
ABC3 – Disclosure of Conflict of Interest
|
|
|
2015 |
24 |
S3 |
p. S76-S77 2 p. |
article |
2 |
Abstract Presenters
|
|
|
2015 |
24 |
S3 |
p. S16-S17 2 p. |
article |
3 |
Abstracts List
|
|
|
2015 |
24 |
S3 |
p. S82-S85 4 p. |
article |
4 |
Author index
|
|
|
2015 |
24 |
S3 |
p. S78-S81 4 p. |
article |
5 |
Award
|
|
|
2015 |
24 |
S3 |
p. S6- 1 p. |
article |
6 |
BP103 ELECTROCHEMOTHERAPY IN THE TREATMENT OF CUTANEOUS METASTASES FROM BREAST CANCER: A MULTICENTER COHORT ANALYSIS
|
Agresti, Roberto |
|
2015 |
24 |
S3 |
p. S57- 1 p. |
article |
7 |
BP129 INSULIN RESISTANCE (IR) AND PROGNOSIS OF METASTATIC BREAST CANCER (MBC) PATIENTS
|
Provinciali, Nicoletta |
|
2015 |
24 |
S3 |
p. S66- 1 p. |
article |
8 |
BP52 IS THERE A DIFFERENT TREATMENT RESPONSE BETWEEN VISCERAL AND NON-VISCERAL METASTATIC BREAST CANCER: A SYSTEMATIC LITERATURE REVIEW OF REGISTRATION TRIALS
|
Würstlein, Rachel |
|
2015 |
24 |
S3 |
p. S39- 1 p. |
article |
9 |
BP38 METASTATIC BREAST CANCER IN CANADA: WAITING FOR TREATMENT
|
Chari, Niya |
|
2015 |
24 |
S3 |
p. S34-S35 2 p. |
article |
10 |
Breast Cancer Patient Advocacy Programme
|
|
|
2015 |
24 |
S3 |
p. S8- 1 p. |
article |
11 |
Chairs and Panel Members
|
|
|
2015 |
24 |
S3 |
p. S6-S7 2 p. |
article |
12 |
Editorial Board
|
|
|
2015 |
24 |
S3 |
p. ii- 1 p. |
article |
13 |
Endorsement and Auspices
|
|
|
2015 |
24 |
S3 |
p. S4- 1 p. |
article |
14 |
General Information
|
|
|
2015 |
24 |
S3 |
p. S2-S3 2 p. |
article |
15 |
High Patronage
|
|
|
2015 |
24 |
S3 |
p. S4- 1 p. |
article |
16 |
IN31 ADDRESSING THE EMOTIONAL NEEDS OF PATIENTS WITH ADVANCED METASTATIC BREAST CANCER
|
Shockney, Lillie D. |
|
2015 |
24 |
S3 |
p. S32- 1 p. |
article |
17 |
IN27 ADVANCED BREAST CANCER: IS THERE AN OPTIMAL SEQUENCE OF SYSTEMIC ANTICANCER AGENTS?
|
Francis, Prudence A. |
|
2015 |
24 |
S3 |
p. S31- 1 p. |
article |
18 |
IN26 BIOPSY, REBIOPSY AND DEALING WITH DISCORDANT RESULTS IN ABC
|
Harbeck, Nadia |
|
2015 |
24 |
S3 |
p. S30-S31 2 p. |
article |
19 |
IN34 BREAST CANCER CARE ACCESS AND AFFORDABILITY: ARE DRUGS THE MAIN ISSUE IN EUROPE?
|
Taylor, David |
|
2015 |
24 |
S3 |
p. S33- 1 p. |
article |
20 |
IN17 CAN IMMUNE-BASED THERAPIES BE THE KEY?
|
Curigliano, Giuseppe |
|
2015 |
24 |
S3 |
p. S27- 1 p. |
article |
21 |
IN35 CAN WE REALLY APPLY INTERNATIONAL GUIDELINES IN LIMITED RESOURCES COUNTRIES?
|
Bhattacharyya, G.S. |
|
2015 |
24 |
S3 |
p. S33-S34 2 p. |
article |
22 |
IN23 CIRCULATING TUMOR CELLS AND TUMOR DNA: ARE LIQUID BIOPSIES A DREAM?
|
Pierga, Jean-Yves |
|
2015 |
24 |
S3 |
p. S29-S30 2 p. |
article |
23 |
IN24 CLONAL EVOLUTION IN BREAST CANCER PATIENTS AND PATIENT DERIVED XENOGRAFTS
|
Aparicio, Sam |
|
2015 |
24 |
S3 |
p. S30- 1 p. |
article |
24 |
IN28 DURATION OF FIRST-LINE CHEMOTHERAPY IN METASTATIC BREAST CANCER
|
Gennari, Alessandra |
|
2015 |
24 |
S3 |
p. S31- 1 p. |
article |
25 |
IN22 DYSPNEA: THE HARDEST SYMPTOM TO CONTROL?
|
Aapro, Matti |
|
2015 |
24 |
S3 |
p. S29- 1 p. |
article |
26 |
IN19 IMAGING RECEPTOR EXPRESSION AND GLYCOLYTIC ACTIVITY USING PET-CT TO INDIVIDUALIZE TREATMENT IN METASTATIC HER2 POSITIVE BREAST CANCER (MBC)
|
Flamen, P. |
|
2015 |
24 |
S3 |
p. S28- 1 p. |
article |
27 |
IN36 IS A TWO-SPEED (RICH VS POOR) ONCOLOGY INEVITABLE?
|
Sledge, George W. |
|
2015 |
24 |
S3 |
p. S34- 1 p. |
article |
28 |
IN14 IS OVARIAN ABLATION MANDATORY IN PRE-MENOPAUSAL ER+ ABC PATIENTS?
|
Bergh, Jonas |
|
2015 |
24 |
S3 |
p. S26- 1 p. |
article |
29 |
IN03 IS THERE AN OPTIMAL TREATMENT SEQUENCE FOR HER2 POSITIVE ADVANCED BREAST CANCER?
|
Arora, Shagun |
|
2015 |
24 |
S3 |
p. S21-S22 2 p. |
article |
30 |
IN06 LIVING ON BORROWED TIME: LONG TERM RESPONDERS
|
Mertz, Shirley A. |
|
2015 |
24 |
S3 |
p. S23- 1 p. |
article |
31 |
IN32 LIVING WITH MBC IS LIKE WALKING ON A TIGHT ROPE, A BALANCING ACT USING ALL RESOURCES, TO HOLD ON AND REACH THE OTHER END
|
Papadopoulos, Evi |
|
2015 |
24 |
S3 |
p. S33- 1 p. |
article |
32 |
IN01 LIVING WITH METASTATIC BONE DISEASE – THE POSITIVE IMPACT OF BONE-TARGETED TREATMENTS
|
Coleman, Robert |
|
2015 |
24 |
S3 |
p. S21- 1 p. |
article |
33 |
IN05 LONG TERM SURVIVAL WITH ADVANCED DISEASE. CHALLENGES FOR THE PATIENT, THEIR SUPPORT SYSTEM AND CARE GIVERS
|
Gelmon, Karen |
|
2015 |
24 |
S3 |
p. S23- 1 p. |
article |
34 |
IN02 METAVIVOR: FIGHTING PREJUDICE
|
Corneliussen-James, CJ (Dian) |
|
2015 |
24 |
S3 |
p. S21- 1 p. |
article |
35 |
IN07 NEW DRUGS, NEW SIDE EFFECTS: ENDOCRINE SIDE EFFECTS
|
Eniu, Alexandra |
|
2015 |
24 |
S3 |
p. S23-S24 2 p. |
article |
36 |
IN21 OPTIMAL MANAGEMENT OF FATIGUE
|
Roila, Fausto |
|
2015 |
24 |
S3 |
p. S29- 1 p. |
article |
37 |
IN04 OPTIMAL MANAGEMENT OF HER-2+ ABC
|
Krop, Ian E. |
|
2015 |
24 |
S3 |
p. S22-S23 2 p. |
article |
38 |
IN15 OPTIMAL MANAGEMENT OF TRIPLE NEGATIVE METASTATIC BREAST CANCER (TODAY)
|
Carey, Lisa A. |
|
2015 |
24 |
S3 |
p. S26-S27 2 p. |
article |
39 |
IN25 PATIENT XENOGRAFT MODELS: CAN AN “AVATAR” HELP?
|
Hoffmann, Jens |
|
2015 |
24 |
S3 |
p. S30- 1 p. |
article |
40 |
IN16 RESURRECTING PARP INHIBITION
|
Tutt, Andrew |
|
2015 |
24 |
S3 |
p. S27- 1 p. |
article |
41 |
IN13 REVOLUTIONIZING ER+ ABC MANAGEMENT: ESR1 AND OTHER SUSPECTS IN RESISTANCE
|
Diéras, Véronique |
|
2015 |
24 |
S3 |
p. S25-S26 2 p. |
article |
42 |
IN29 SURGERY OF THE PRIMARY TUMOUR: SHOULD THE RECOMMENDATION BE CHANGED?
|
Cardoso, Maria-João |
|
2015 |
24 |
S3 |
p. S31-S32 2 p. |
article |
43 |
IN30 SURVIVORSHIP IN ABC: WHICH ARE THE MAIN ISSUES?
|
Pagani, Olivia |
|
2015 |
24 |
S3 |
p. S32- 1 p. |
article |
44 |
IN33 THE COST OF BREAST CANCER: A GLOBAL PERSPECTIVE
|
Sullivan, Richard |
|
2015 |
24 |
S3 |
p. S33- 1 p. |
article |
45 |
IN12 THE ROLE OF CDK AND PI3K/MTOR INHIBITORS
|
André, Fabrice |
|
2015 |
24 |
S3 |
p. S25- 1 p. |
article |
46 |
IN10 THE ROLE OF PATIENT REPORTED OUTCOMES
|
Fallowfield, Lesley |
|
2015 |
24 |
S3 |
p. S25- 1 p. |
article |
47 |
IN20 TOWARDS IMPROVED DISEASE OUTCOME COMBINED WITH A REDUCTION OF TOXICITY USING NEW RADIATION THERAPY TECHNIQUES
|
Meijer, Hanneke J.M. |
|
2015 |
24 |
S3 |
p. S28- 1 p. |
article |
48 |
IN09 TOXICITY OF MODERN IMMUNOTHERAPY APPROACHES
|
Barrios, Carlos H. |
|
2015 |
24 |
S3 |
p. S24-S25 2 p. |
article |
49 |
IN08 TREATMENT ASSOCIATED RISKS: IDENTIFYING AND TREATING PULMONARY TOXICITY
|
Rugo, Hope S. |
|
2015 |
24 |
S3 |
p. S24- 1 p. |
article |
50 |
IN18 TRIPLE NEGATIVE BREAST CANCER: THE ROLE OF ANDROGEN RECEPTOR AND ITS INHIBITORS
|
Hudis, Clifford A. |
|
2015 |
24 |
S3 |
p. S27-S28 2 p. |
article |
51 |
OR128 CTL AND IGG RESPONSE TO TUMOR-ASSOCIATED ANTIGENS AS PREDICTIVE FACTORS OF THERAPEUTIC PEPTIDE VACCINATION FOR PATIENTS WITH METASTATIC RECURRENT BREAST CANCER
|
Toh, Uhi |
|
2015 |
24 |
S3 |
p. S65-S66 2 p. |
article |
52 |
OR51 NO IMPACT OF INCREASING SYMPTOMS ON QUALITY OF LIFE? LONGITUDINAL DATA FROM THE GERMAN MALIFE-PROJECT ON PATIENTS RECEIVING MONOCHEMO- AND ENDOCRINE TREATMENT FOR ADVANCED BREAST CANCER – RESULTS FROM THE TMK REGISTRY GROUP
|
Marschner, Norbert |
|
2015 |
24 |
S3 |
p. S39- 1 p. |
article |
53 |
OR37 UNMET PSYCHOSOCIAL AND QUALITY OF LIFE NEEDS OF PATIENTS LIVING WITH METASTATIC BREAST CANCER
|
Hurlbert, Marc |
|
2015 |
24 |
S3 |
p. S34- 1 p. |
article |
54 |
P096 CHARACTERISATION OF BREAST CANCER BRAIN METASTASES THROUGH A 21-YEAR PERIOD – A STUDY FROM THE SWEDISH ASSOCIATION OF BREAST ONCOLOGISTS (SABO)
|
Thulin, Anna |
|
2015 |
24 |
S3 |
p. S54-S55 2 p. |
article |
55 |
P077 LOCALLY ADVANCED BREAST CANCER IN YOUNG FEMALE. THE EGYPTIAN NATIONAL CANCER INSTITUTE EXPERIENCE
|
Helal, Amany |
|
2015 |
24 |
S3 |
p. S48- 1 p. |
article |
56 |
PO134 ANALYSIS OF PRIMARY BREAST CANCER (BC) EXPRESSION OF PROGRAMMED CELL DEATH 1 (PD-1) RECEPTOR AND PROGRAMMED DEATH LIGAND 1 (PD-L1) TO DETERMINE ASSOCIATIONS WITH CLINICAL CHARACTERISTICS AND OUTCOMES
|
Vidula, Neelima |
|
2015 |
24 |
S3 |
p. S67-S68 2 p. |
article |
57 |
PO132 APOPTOTIC ACTIVITIES OF RECOMBINANT CELL SURFACE RECEPTOR FAS WITHIN TUMOR MICROENVIRONMENT OF BREAST CARCINOMA
|
Abou-Shousha, Seham Abdel-Moneim |
|
2015 |
24 |
S3 |
p. S67- 1 p. |
article |
58 |
PO54 A RETROSPECTIVE MULTICENTER OBSERVATION STUDY IN METASTATIC BREAST CANCER PATIENTS: COMPARATIVE ANALYSIS ON EFFICACY OF ERIBULIN MESYLATE WITH TAXANE REGIMENS (INCLUDING COMBINATION WITH BEVACIZUMAB)
|
Kikuchi, Yasuko |
|
2015 |
24 |
S3 |
p. S40- 1 p. |
article |
59 |
PO135 AT A GLANCE THE BRCAS EPIGENETIC STUDY IN PADANG, WEST SUMATERA, INDONESIA
|
Harahap, Wirsma Arif |
|
2015 |
24 |
S3 |
p. S68- 1 p. |
article |
60 |
PO56 BOLERO-4: A PHASE 2, OPEN-LABEL, MULTICENTER, SINGLE-ARM TRIAL INVESTIGATING THE EFFICACY AND SAFETY OF FIRST-LINE EVEROLIMUS (EVE) IN COMBINATION WITH LETROZOLE (LET) IN POSTMENOPAUSAL PATIENTS (PTS) WITH ESTROGEN RECEPTOR–POSITIVE (ER+), HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2–NEGATIVE (HER2–) METASTATIC OR LOCALLY ADVANCED UNRESECTABLE BREAST CANCER (BC)
|
Bachelot, Thomas |
|
2015 |
24 |
S3 |
p. S41- 1 p. |
article |
61 |
PO69 BRACHIAL PLEXOPATHY IN METASTATIC BREAST CANCER: A REVIEW OF PATIENT CHARACTERISTICS AND DIAGNOSIS IN AN IRISH TERTIARY REFERRAL CENTRE
|
O'Leary, Connor |
|
2015 |
24 |
S3 |
p. S45-S46 2 p. |
article |
62 |
PO97 BRAIN METASTASES IN HER2- POSITIVE BREAST CANCER PATIENTS: A SINGLE INSTITUTE EXPERIENCE
|
Mehmood, Tahir |
|
2015 |
24 |
S3 |
p. S55- 1 p. |
article |
63 |
PO117 CAN WE MAKE A PORTRAIT OF WOMEN WITH INOPERABLE LOCALLY ADVANCED BREAST CANCER? THE EXPERIENCE OF THE BREAST UNIT OF SOUTHERN SWITZERLAND (CSSI)
|
Montagna, Giacomo |
|
2015 |
24 |
S3 |
p. S62- 1 p. |
article |
64 |
PO140 CHANGING IN TUMOR BIOLOGY OF TRIPLE NEGATIVE BREAST CANCER BETWEEN PRIMARY AND METASTATIC LESIONS
|
Milovic-Kovacevic, Marijana |
|
2015 |
24 |
S3 |
p. S70- 1 p. |
article |
65 |
PO57 CLINICAL EFFICACY OF LH-RH ANALOGUE PLUS AROMATASE INHIBITOR IN PREMENOPAUSAL WOMEN WITH ESTROGEN RECEPTOR–POSITIVE ADVANCED BREAST CANCER: A SINGLE-INSTITUTION RETROSPECTIVE STUDY
|
Utsumi, Toshiaki |
|
2015 |
24 |
S3 |
p. S41- 1 p. |
article |
66 |
PO53 CLINICAL IMPACT OF METRONOMIC ORAL COMBINATION CHEMOTHERAPY WITH CAPECITABINE AND CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST CANCER
|
Fujihara, Miwa |
|
2015 |
24 |
S3 |
p. S40- 1 p. |
article |
67 |
PO130 CLINICAL UTILITY OF THE EXPRESSION OF HER3, HER4, PTEN AND IGF1R IN HER2-POSITIVE ADVANCED OR METASTATIC BREAST CANCER
|
Ito, Hiroki |
|
2015 |
24 |
S3 |
p. S66- 1 p. |
article |
68 |
PO81 COMPLIANCE AND PERSISTENCE TO PALLIATIVE ENDOCRINE THERAPY IN METASTATIC BREAST CANCER
|
Güth, Uwe |
|
2015 |
24 |
S3 |
p. S49-S50 2 p. |
article |
69 |
PO63 CURE IN METASTATIC BREAST CANCER: AN AGGRESSIVE APPROACH DOES NOT APPEAR TO BE THE KEY TO THE BLACK BOX
|
Güth, Uwe |
|
2015 |
24 |
S3 |
p. S43-S44 2 p. |
article |
70 |
PO83 CURRENT STATUS OF THE MANAGEMENT OF ADVANCED RH+/HER2-BREAST CANCER IN MOROCCO
|
Hassan, Errihani |
|
2015 |
24 |
S3 |
p. S50- 1 p. |
article |
71 |
PO133 DIFFERENTIAL EXPRESSION OF PLASMA MEMBRANE PROTEINS IN INFLAMMATORY BREAST CANCER VIA STABLE ISOTOPE LABELED AMINO ACIDS IN CULTURE (SILAC)
|
Martinez-Montemayor, Michelle M. |
|
2015 |
24 |
S3 |
p. S67- 1 p. |
article |
72 |
PO58 DOES PREVIOUS NEOADJUVANT/ADJUVANT TRASTUZUMAB INFLUENCE THE DISEASE OUTCOME OF METASTATIC HER2 POSITIVE BREAST CANCER PATIENTS TREATED WITH FIRST LINE TRASTUZUMAB AND CHEMOTHERAPY
|
Milosevic, Snezana |
|
2015 |
24 |
S3 |
p. S41-S42 2 p. |
article |
73 |
PO59 DURABLE REMISSIONS WITH TRASTUZUMAB TREATMENT FOR HER2 POSITIVE METASTATIC BREAST CANCER – SINGLE CENTER EXPERIENCE
|
Tomasevic, Zoran |
|
2015 |
24 |
S3 |
p. S42- 1 p. |
article |
74 |
PO39 EFFECTIVE ADVOCACY FOR WOMEN WITH METASTATIC BREAST CANCER: A EUROPEAN PERSPECTIVE
|
Knox, Susan |
|
2015 |
24 |
S3 |
p. S35- 1 p. |
article |
75 |
PO55 EFFICACY AND SAFETY OF ERIBULIN IN ANTHRACYCLINE AND TAXANE-PRETREATED PATIENTS: RUSSIAN EXPERIENCE
|
Kovalenko, Elena |
|
2015 |
24 |
S3 |
p. S40- 1 p. |
article |
76 |
PO112EFFICACY OF NEPA, THE FIRST COMBINATION ANTIEMETIC AGENT, IN PATIENTS WITH BREAST CANCER RECEIVING ANTHRACYCLINE/CYCLOPHOSPHAMIDE (AC) OR NON-AC CHEMOTHERAPY
|
Rugo, Hope |
|
2015 |
24 |
S3 |
p. S60- 1 p. |
article |
77 |
PO79 ELDERLY METASTATIC BREAST CANCER AT DIAGNOSIS: A SINGLE INSTITUTION EXPERIENCE
|
Carvalho, Amanda Nobre |
|
2015 |
24 |
S3 |
p. S49- 1 p. |
article |
78 |
PO78 ELDERLY WOMEN AND BREAST CANCER: CHARACTERIZATION OF TREATMENT PRACTICES
|
Freitas, Diana |
|
2015 |
24 |
S3 |
p. S48-S49 2 p. |
article |
79 |
PO80 ELEVATED NEUTROPHIL TO LYMPHOCYTE RATIO PREDICTS WORSE SURVIVAL OUTCOME AFTER RECURRENCE FOR PATIENTS WITH TRIPLE NEGATIVE BREAST CANCER
|
Iwase, Toshiaki |
|
2015 |
24 |
S3 |
p. S49- 1 p. |
article |
80 |
PO82 EPIDEMIOLOGY AND THERAPEUTIC MANAGEMENT OF METASTATIC BREAST CANCER IN BULGARIA: A RETROSPECTIVE COHORT STUDY
|
Timcheva, Konstanta |
|
2015 |
24 |
S3 |
p. S50- 1 p. |
article |
81 |
PO70 ESTROGEN RECEPTOR AS A NEGATIVE PREDICTOR OF COMPLETE PATHOLOGICAL RESPONSE IN HER2 POSITIVE LOCALLY ADVANCED BREAST CANCER
|
Canario, Rita |
|
2015 |
24 |
S3 |
p. S46- 1 p. |
article |
82 |
PO142 EVOLUTION OF THE EXPRESSION OF CIRCULATING TUMOR CELLS (CTC) AND CK-19 MRNA (CK19) AS PROGNOSTIC FACTORS IN HEAVILY PRETREATED METASTATIC BREAST CANCER
|
Murillo, Serafín Morales |
|
2015 |
24 |
S3 |
p. S70-S71 2 p. |
article |
83 |
PO43 “FIGHT, LIVE, KEEP SMILING”: THE FIRST ITALIAN BLOG ABOUT METASTATIC BREAST CANCER (MBC) ADDRESSED TO THE GENERAL PUBLIC. A QUALI-QUANTITATIVE ANALYSIS OF ALL THE COMMENTS POSTED ONLINE ON THE BLOG OF THE EUROPA DONNA ITALIA MBC WORKING GROUP
|
Balena, Francesca |
|
2015 |
24 |
S3 |
p. S36-S37 2 p. |
article |
84 |
PO62 FIRST LINE TRASTUZUMAB-BASED THERAPY IN HER2-POSITIVE METASTATIC BREAST CANCER PATIENTS PRESENTING WITH DE NOVO OR RECURRENT DISEASE: A MULTICENTER RETROSPECTIVE COHORT STUDY
|
Lambertini, Matteo |
|
2015 |
24 |
S3 |
p. S43- 1 p. |
article |
85 |
PO131 HETEROGENEITY IN THE EXPRESSION OF HORMONE RECEPTORS AND HER2 BETWEEN THE PRIMARY BREAST CANCER AND PULMONARY METASTASIS
|
Sato, Masako |
|
2015 |
24 |
S3 |
p. S66-S67 2 p. |
article |
86 |
PO46 I AM ANNA: EXPLORING METASTATIC BREAST CANCER THROUGH THE EYES OF A YOUNG WOMAN
|
Ginsberg, Shawna |
|
2015 |
24 |
S3 |
p. S37- 1 p. |
article |
87 |
PO145 ICORG 13-01 ABC SURVEY: ARE WE MEETING THE NEEDS OF PATIENTS WITH ADVANCED BREAST CANCER (ABC) IN IRELAND? A NATIONWIDE SURVEY
|
Battley, Jodie E. |
|
2015 |
24 |
S3 |
p. S71-S72 2 p. |
article |
88 |
PO47 IDENTIFYING DEFICITS AND NEEDS FROM STAKEHOLDERS ABOUT PALLIATIVE CARE ISSUES
|
Pramod, Shankpal |
|
2015 |
24 |
S3 |
p. S37-S38 2 p. |
article |
89 |
PO100 IMRT-SIB FOR LOCALLY ADVANCED INOPERABLE BREAST CANCER PATIENTS
|
Gabrys, Dorota |
|
2015 |
24 |
S3 |
p. S56- 1 p. |
article |
90 |
PO45 INFORMATION NEEDS OF YOUNG WOMEN WITH METASTATIC BREAST CANCER TO MANAGE THEIR TREATMENT, SIDE EFFECTS AND CLINICAL TRIALS
|
Sutliff, Medha |
|
2015 |
24 |
S3 |
p. S37- 1 p. |
article |
91 |
PO44 IN OUR SHOES: RAISING THE VOICES OF MBC PATIENTS
|
Marx-Rubiner, Lori |
|
2015 |
24 |
S3 |
p. S37- 1 p. |
article |
92 |
PO98 IS BRAIN METASTASES LOCATION ASSOCIATED WITH PROGNOSIS IN BREAST CANCER PATIENTS?
|
Widera, Karolina |
|
2015 |
24 |
S3 |
p. S55- 1 p. |
article |
93 |
PO42 MAKE YOUR DIALOGUE COUNT SURVEY: ADDRESSING COMMUNICATION GAPS BETWEEN PATIENTS WITH ADVANCED BREAST CANCER, THEIR CAREGIVERS AND ONCOLOGISTS AND UNDERSTANDING INFORMATION AND EMOTIONAL NEEDS TO IMPROVE TREATMENT AND SIDE EFFECT MANAGEMENT
|
Coons, Helen L. |
|
2015 |
24 |
S3 |
p. S36- 1 p. |
article |
94 |
PO110 METASTASES OF LOBULAR BREAST CARCINOMA IN THE TERMINAL ILEUM AND ILEOCAECAL VALVE
|
Abdalla, Sala |
|
2015 |
24 |
S3 |
p. S59- 1 p. |
article |
95 |
PO64 METRONOMIC CHEMOTHERAPY (CHT) COMBINATION OF VINORELBINE (VRL) AND CAPECITABINE (CAPE) IN HER2- ADVANCED BREAST CANCER (ABC) PATIENTS (PTS) DOES NOT IMPAIR GLOBAL QOL. FIRST RESULTS OF THE VICTOR-2 STUDY
|
Elena Cazzaniga, Marina |
|
2015 |
24 |
S3 |
p. S44- 1 p. |
article |
96 |
PO41 MIDDLE EASTERN ABC/MBC PATIENTS:OVERCOMING THE TRIPLE-BURDEN OF STIGMATIZATION, LACK OF INFORMATION AND RECURRENT ILLNESS
|
Azmi, Rania |
|
2015 |
24 |
S3 |
p. S36- 1 p. |
article |
97 |
PO71 MONITORING THERAPY RESPONSE IN METASTATIC BREAST CANCER USING TUMOUR MARKERS CA15-3 AND TPS
|
Sundquist, Marie |
|
2015 |
24 |
S3 |
p. S46- 1 p. |
article |
98 |
PO66 NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED BREAST CANCER; A SOLUTION TO AVOID MASTECTOMY
|
Tarek Awad, Ahmed |
|
2015 |
24 |
S3 |
p. S44-S45 2 p. |
article |
99 |
PO67 NEO-ADJUVANT HORMONAL THERAPY FOR LOCALLY ADVANCED BREAST CANCER
|
Katselashvili, Lika |
|
2015 |
24 |
S3 |
p. S45- 1 p. |
article |
100 |
PO106 N2 LYMPH NODES POST-PRIMARY CHEMOTHERAPY MAY PREDICT RECURRENCE IN LOCALLY ADVANCED BREAST CANCER
|
Ann Benn, Carol |
|
2015 |
24 |
S3 |
p. S58- 1 p. |
article |
101 |
PO108 NOVEL AND SAFE TECHNIQUES IN IMMEDIATE BREAST RECONSTRUCTION FOR LOCALLY ADVANCED BREAST CANCER, PARTICULARLY INFLAMMATORY BREAST CANCER
|
Venter, Marisse |
|
2015 |
24 |
S3 |
p. S59- 1 p. |
article |
102 |
PO61 ORAL VINORELBINE IN COMBINATION WITH TRASTUZUMAB AS A FIRST LINE THERAPY OF METASTATIC OR LOCALLY ADVANCED HER2-POSITIVE BREAST CANCER
|
Farhat, Fadi |
|
2015 |
24 |
S3 |
p. S42-S43 2 p. |
article |
103 |
PO73 OUTPATIENT CATUMAXOMAB THERAPY IN METASTATIC BREAST CANCER PATIENTS SUFFERING FROM MALIGNANT EFFUSIONS DUE TO PERITONEAL OR PLEURAL CARCINOMATOSIS: A SINGLE INSTITUTION EXPERIENCE
|
Martin Kurbacher, Christian |
|
2015 |
24 |
S3 |
p. S47- 1 p. |
article |
104 |
PO138 P-CADHERIN: A CANDIDATE BIOMARKER FOR AXILLARY-BASED BREAST CANCER DECISIONS IN CLINICAL PRACTICE
|
Dionisio, Maria Rita |
|
2015 |
24 |
S3 |
p. S69- 1 p. |
article |
105 |
PO65 PHASE II TRIAL OF METRONOMIC COMBINATION CHEMOTHERAPY WITH ORAL REGIMEN IN HEAVILY PRETREATED METASTATIC BREAST CANCER
|
Rammohan, Prasanna |
|
2015 |
24 |
S3 |
p. S44- 1 p. |
article |
106 |
PO101 PROGNOSTIC FACTORS AFTER GAMMA KNIFE RADIOSURGERY IN BREAST CANCER PATIENTS WITH BRAIN METASTASES
|
Hayama, Shoko |
|
2015 |
24 |
S3 |
p. S56- 1 p. |
article |
107 |
PO143 PROGNOSTIC IMPACT OF CIRCULATING TUMOR CELL CLUSTERS AND APOPTOSIS IN METASTATIC BREAST CANCER
|
Jansson, Sara |
|
2015 |
24 |
S3 |
p. S71- 1 p. |
article |
108 |
PO139 RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B (RANK) EXPRESSION IN PRIMARY BREAST CANCER CORRELATES WITH RECURRENCE FREE SURVIVAL AND DEVELOPMENT OF BONE METASTASES IN THE I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
|
Vidula, Neelima |
|
2015 |
24 |
S3 |
p. S69-S70 2 p. |
article |
109 |
PO122 SODIUM FLUORIDE PET/CT: A SUPERIOR IMAGING MODALITY IN EVALUATION OF OSSEOUS METASTATIC DISEASE
|
Harrold, Emily |
|
2015 |
24 |
S3 |
p. S63-S64 2 p. |
article |
110 |
Poster Session
|
|
|
2015 |
24 |
S3 |
p. S18-S19 2 p. |
article |
111 |
PO105 SUCCESS AND FAILURE OF PRIMARY MEDICAL, NON-OPERATIVE MANAGEMENT IN PATIENTS WHO PRESENT WITH STAGE IV BREAST CANCER
|
Güth, Uwe |
|
2015 |
24 |
S3 |
p. S58- 1 p. |
article |
112 |
PO141 SUCCESSFUL USE OF HER2 TARGETED AGENTS IN PATIENTS WITH HEAVILY PRETREATED HER2-NEGATIVE METASTATIC BREAST CANCER PRESENTING WITH ELEVATED SERUM LEVELS OF THE HER2 EXTRACELLULAR DOMAIN AND/OR HER2 OVEREXPRESSING CIRCULATING TUMOR CELLS
|
Kurbacher, Christian Martin |
|
2015 |
24 |
S3 |
p. S70- 1 p. |
article |
113 |
PO107 SURGICAL RESECTION OF THE PRIMARY TUMOR IS ASSOCIATED WITH INCREASED LONG-TERM SURVIVAL IN PATIENTS WITH STAGE IV BREAST CANCER
|
Sukhotko, Anna |
|
2015 |
24 |
S3 |
p. S58-S59 2 p. |
article |
114 |
PO144 SYNERGISTIC ANTITUMOR EFFECTS OF CROCIN COMBINED WITH HYPERTHERMIA ON BREAST CANCER CELLS
|
Hoshyar, Reyhane |
|
2015 |
24 |
S3 |
p. S71- 1 p. |
article |
115 |
PO48 TERMINOLOGY USED IN ADVANCED BREAST CANCER AND THE NEED FOR CONSISTENCY
|
Leadbeater, Maria |
|
2015 |
24 |
S3 |
p. S38- 1 p. |
article |
116 |
PO75 THE CTPET/MDST RATIO: AN INTRODUCTION OF A QUANTITATIVE MEASURE OF EFFECTIVE PALLIATIVE ENDOCRINE THERAPY IN METASTATIC BREAST CANCER
|
Güth, Uwe |
|
2015 |
24 |
S3 |
p. S47-S48 2 p. |
article |
117 |
PO115 THE EMOTIONAL TOLL OF METASTATIC BREAST CANCER ON YOUNG WOMEN
|
Sutliff, Medha |
|
2015 |
24 |
S3 |
p. S61- 1 p. |
article |
118 |
PO109 THE IMPACT OF LOCOREGIONAL TREATMENT OF PRIMARY METASTATIC BREAST CANCER
|
Liubota, Roman |
|
2015 |
24 |
S3 |
p. S59- 1 p. |
article |
119 |
PO116 THE LAST QUARTER OF A HONEYMOON – A WEDDING'S STORY
|
Pereira, Jose |
|
2015 |
24 |
S3 |
p. S61-S62 2 p. |
article |
120 |
PO72 THERAPEUTIC EFFECT PREDICTION BASED ON BIOMARKERS IN THE PLEURAL EFFUSION SPECIMENS OF BREAST CANCER PATIENTS
|
Nakamura, Rikiya |
|
2015 |
24 |
S3 |
p. S46-S47 2 p. |
article |
121 |
PO76 THERAPEUTIC STRATEGY FOR RECURRENT HER2-POSITIVE BREAST CANCER PATIENTS
|
Nishimura, Akimasa |
|
2015 |
24 |
S3 |
p. S48- 1 p. |
article |
122 |
PO60 THE ROLE OF LAPATINIB IN THE MANAGEMENT OF HER2-POSITIVE METASTATIC BREAST CANCER: A REVIEW OF A SINGLE INSTITUTION'S EXPERIENCE DURING THE TRASTUZUMAB AND LAPATINIB ERA
|
Watanabe, Junichiro |
|
2015 |
24 |
S3 |
p. S42- 1 p. |
article |
123 |
PO104 THE SURGICAL MANAGEMENT OF LUNG NODULES IN BREAST CANCER PATIENTS
|
Matsuura, Kazuo |
|
2015 |
24 |
S3 |
p. S57-S58 2 p. |
article |
124 |
PO99 TREATMENT OUTCOMES OF BREAST CANCER BRAIN METASTASES
|
Ratosa, Ivica |
|
2015 |
24 |
S3 |
p. S55-S56 2 p. |
article |
125 |
PO68 TRIPLE NEGATIVE BREAST CANCER – NEOADJUVANT CHEMOTHERAPY RESPONSE EVALUATION WITH TAXANE/ANTHRACYCLINE PROTOCOL – SINGLE CENTRE 5 YEARS EXPERIENCE
|
de Paulo, Judy Vicente |
|
2015 |
24 |
S3 |
p. S45- 1 p. |
article |
126 |
PO40 UNMET NEEDS OF AUSTRALIAN WOMEN WITH METASTATIC BREAST CANCER WITH FINANCIALLY DEPENDENT CHILDREN: THE CONSUMER PERSPECTIVE
|
Spence, Danielle |
|
2015 |
24 |
S3 |
p. S35- 1 p. |
article |
127 |
PO114 USING OF HEPATOPROTECTORS IN THE DRUG TREATMENT OF PATIENTS WITH ADVANCED BREAST CANCER
|
Ibragimov, Jamshid |
|
2015 |
24 |
S3 |
p. S61- 1 p. |
article |
128 |
PO74 WHICH IS MORE BENEFICIAL AS AN INITIAL THERAPY FOR THE FIRST DISTANT METASTASIS OF BREAST CANCER: CHEMOTHERAPY OR ENDOCRINE THERAPY FOR HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE BREAST CANCER PATIENTS? A SINGLE-CENTER STUDY
|
Yamamura, Jun |
|
2015 |
24 |
S3 |
p. S47- 1 p. |
article |
129 |
PR126 ACCESS TO CARE FOR ADVANCED BREAST CANCER IN MIDDLE-INCOME COUNTRY: EXAMPLE OF MOROCCO
|
Berrada, Narjiss |
|
2015 |
24 |
S3 |
p. S65- 1 p. |
article |
130 |
PR148 ANDROGEN RECEPTOR (AR) EXPRESSION AS A PROMISING INDEX OF THE PREDICTION OF DISTANT METASTASIS OF TRIPLE NEGATIVE BREAST CANCER (TNBC)
|
Miwa, Noriko |
|
2015 |
24 |
S3 |
p. S73- 1 p. |
article |
131 |
PR90 BASIC CLINICAL ISSUES OF INFLAMMATORY CARCINOMA OF THE BREAST
|
Bebeci-Docaj, Arjeta |
|
2015 |
24 |
S3 |
p. S52-S53 2 p. |
article |
132 |
PR127 CHANGES OF STATISTICS OF BREAST CANCER IN UKRAINE DURING THE PERIOD OF 2003-2013
|
Zrelykh, Liliya |
|
2015 |
24 |
S3 |
p. S65- 1 p. |
article |
133 |
PR87 COMBINATION THERAPY PERUZUMAB, TRASTUZUMAB AND DOCETAXEL FOR ADVANCED OR RECURRENT BREAST CANCER PATIENTS IN THE LATE LINE
|
Morimoto, Takashi |
|
2015 |
24 |
S3 |
p. S51- 1 p. |
article |
134 |
PR113 COMPARATIVE ASSESSMENT OF ANALGESIC THERAPY IN PATIENTS WITH BREAST CANCER IN THE TERMINAL STAGE
|
Kadirova, Zulaykho |
|
2015 |
24 |
S3 |
p. S60-S61 2 p. |
article |
135 |
PR118 COMPARISON OF INTEGRATIVE CARE EXPECTATIONS BETWEEN BREAST CANCER PATIENTS AND BREAST ONCOLOGY PHYSICIANS IN AN ETHNICALLY DIVERSE POPULATION
|
Hansra, Damien |
|
2015 |
24 |
S3 |
p. S62- 1 p. |
article |
136 |
PR137 CONTRADICTORIES IN VITAMIN D SUPPLEMENTATION ON GENE EXPRESSION OF MICRORNAS INVOLVING IN BREAST CARCINOGENESIS
|
Koujan, Soraiya Ebrahimpour |
|
2015 |
24 |
S3 |
p. S69- 1 p. |
article |
137 |
PR120 DIFFICULTIES IN PROVIDING PALLIATIVE CARE IN RURAL INDIA (WEST BENGAL) – EXPERIENCE OF AN NGO
|
Manna, Aditya |
|
2015 |
24 |
S3 |
p. S63- 1 p. |
article |
138 |
PR151 EFFECTS OF PHYTOESTROGEN EXTRACTS ISOLATED FROM ELDER FLOWER ON HORMONE PRODUCTION AND RECEPTOR EXPRESSION OF TROPHOBLAST TUMOUR CELLS JEG-3 AND BEWO, AS WELL AS MCF-7 BREAST CANCER CELLS
|
Schröder, Lennard |
|
2015 |
24 |
S3 |
p. S74- 1 p. |
article |
139 |
PR154 EVALUATION OF CARDIOTOXICITY IN BREAST CANCER PATIENTS WITH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-2 OVEREXPRESSION UNDERGOING TRASUZUMAB TREATMENT
|
Zenovia Antone, Nicoleta |
|
2015 |
24 |
S3 |
p. S74-S75 2 p. |
article |
140 |
PR88 EXPERIENCE WITH ERIBULIN IN THE TREATMENT OF METASTATIC BREAST CANCER IN TATARSTAN REPUBLIC CLINICAL ONCOLOGICAL DISPENSARY
|
Khasanova, Alfyia |
|
2015 |
24 |
S3 |
p. S52- 1 p. |
article |
141 |
PR84 FULVESTRANT COMBINED WITH CAPECITABINE MAY BE EFFECTIVE AND WELL TOLERATED FOR PATIENTS WITH ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE METASTATIC BREAST CANCER
|
Nakai, Maki |
|
2015 |
24 |
S3 |
p. S50-S51 2 p. |
article |
142 |
PR49 GETTING BACK INTO LIFE
|
Mueseler, Shirley Bianca |
|
2015 |
24 |
S3 |
p. S38- 1 p. |
article |
143 |
PR89 INFLAMMATORY BREAST CANCER – DOES DERMAL LYMPHATIC INVASION INFLUENCE THE OUTCOME?
|
Kolarevic, Daniela |
|
2015 |
24 |
S3 |
p. S52- 1 p. |
article |
144 |
PR147 INTRATUMORAL MORPHOLOGICAL HETEROGENEITY OF BREAST CANCER AND ITS IMPLICATION IN CHEMOTHERAPY RESISTANCE
|
Gerashchenko, Tatiana |
|
2015 |
24 |
S3 |
p. S72- 1 p. |
article |
145 |
PR152 IS NGS STILL EFFICIENT IN FINDING NEW GENES FOR BREAST CANCER?
|
Kashyap, Aniruddh |
|
2015 |
24 |
S3 |
p. S74- 1 p. |
article |
146 |
PR146 LOCOREGIONAL RECURRENCE BY TUMOR BIOLOGY IN BREAST CANCER PATIENTS AFTER PREOPERATIVE CHEMOTHERAPY AND BREAST CONSERVATION TREATMENT
|
Jwa, Eunjin |
|
2015 |
24 |
S3 |
p. S72- 1 p. |
article |
147 |
PR92 NATIONAL CLINICAL BREAST CANCER REGISTRY: VIEWS AND APPROACHES
|
Pramod, S. |
|
2015 |
24 |
S3 |
p. S53- 1 p. |
article |
148 |
PR91 NO PALLIATIVE SYSTEMIC ANTINEOPLASTIC THERAPY IN PATIENTS WITH DISTANT METASTATIC BREAST CANCER: A BLIND SPOT IN THE PERCEPTION OF ONCOLOGY?
|
Güth, Uwe |
|
2015 |
24 |
S3 |
p. S53- 1 p. |
article |
149 |
Programme
|
|
|
2015 |
24 |
S3 |
p. S9-S13 5 p. |
article |
150 |
PR85 OUR TREATMENT STRATEGY FOR PATIENTS WITH HORMONE-RECEPTOR-POSITIVE, HER2-POSITIVE METASTATIC BREAST CANCER
|
Tanaka, Haruo |
|
2015 |
24 |
S3 |
p. S51- 1 p. |
article |
151 |
PR95 PARANEOPLASTIC CEREBELLAR DEGENERATION AND BREAST CANCER
|
Freitas, Diana |
|
2015 |
24 |
S3 |
p. S54- 1 p. |
article |
152 |
PR123 PATIENTS’ OWN DECISION ABOUT BECOMING AWARE OF RECURRENCE EARLIER
|
Ishige, Hiroyuki |
|
2015 |
24 |
S3 |
p. S64- 1 p. |
article |
153 |
PR136 PREDICTIVE VALUE OF MRNA EXPRESSION OF TUBβIII GENE IN THE TREATMENT OF LOCALLY ADVANCED BREAST CANCER
|
Semiglazova, Tatiana |
|
2015 |
24 |
S3 |
p. S68- 1 p. |
article |
154 |
PR150 PROGNOSTIC IMPACT OF 25-HYDROXYVITAMIN D LEVELS IN EGYPTIAN PATIENTS WITH BREAST CANCER
|
El Shorbagy, Shereen |
|
2015 |
24 |
S3 |
p. S73-S74 2 p. |
article |
155 |
PR149 PROGNOSTIC SIGNIFICANCE OF KI67 PROTEIN EXPRESSION IN METASTATIC BREAST CANCER SURVIVAL
|
Todorovic-Rakovic, Natasa |
|
2015 |
24 |
S3 |
p. S73- 1 p. |
article |
156 |
PR50 PSYCHOLOGICAL SUPPORT TO CANCER PATIENT THROUGH VOLUNTEERS AND SURVIVORS
|
Manna, Aditya |
|
2015 |
24 |
S3 |
p. S38-S39 2 p. |
article |
157 |
PR86 RETROSPECTIVE STUDY OF EVEROLIMUS WITH FULVESTRANT IN POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE METASTATIC BREAST CANCER PRETREATED WITH AROMATASE INHIBITORS(AI'S) AND SELECTIVE ESTROGEN MODIFIERS
|
Vanacker, Leen |
|
2015 |
24 |
S3 |
p. S51- 1 p. |
article |
158 |
PR124 RUMINATION AND CANCER DISEASE: A CROSS-SECTIONAL STUDY IN A COHORT OF PATIENTS WITH BREAST AND LUNG CANCER
|
Riva, Silvia |
|
2015 |
24 |
S3 |
p. S64- 1 p. |
article |
159 |
PR119 SENSITIZING PRIMARY HEALTHCARE WORKERS TOWARDS PSYCHOSOCIAL ISSUES OF BREAST-CANCER PATIENTS
|
Pramod, S. |
|
2015 |
24 |
S3 |
p. S62-S63 2 p. |
article |
160 |
PR125 SOME PATTERNS OF BREAST CANCER EPIDEMIOLOGY
|
Ninashvili, Nanuli |
|
2015 |
24 |
S3 |
p. S64- 1 p. |
article |
161 |
PR102 STERNAL RECURRENCE IN TREATED PATIENTS OF ADVANCED STAGE CARCINOMA BREAST - AN EMERGING ENTITY
|
Kumar, Divyesh |
|
2015 |
24 |
S3 |
p. S56-S57 2 p. |
article |
162 |
PR111 SURGICAL TREATMENT OF ADVANCED BREAST CANCER. URGENCY OF THE PROBLEM
|
Myasnyankin, Michail J. |
|
2015 |
24 |
S3 |
p. S60- 1 p. |
article |
163 |
PR121 TELEPHONIC COMMUNICATION IN PALLIATIVE CARE FOR BETTER MANAGEMENT OF TERMINAL CANCER PATIENTS IN RURAL INDIA AN NGO BASED APPROACH
|
Manna, Aditya |
|
2015 |
24 |
S3 |
p. S63- 1 p. |
article |
164 |
PR93 THE CHANGES OF PLATELET-LYMPHOCYTE RATIO AS A SENSITIVE TUMOR MARKER TO PREDICT PROGRESSION IN METASTATIC BREAST CANCER
|
Kashiwaba, Masahiro |
|
2015 |
24 |
S3 |
p. S53- 1 p. |
article |
165 |
PR94 TUMOR MARKER (CA 15-3) MONITORING FAILED TO DETECT DISEASE RELAPSE AND TRIGGERED UNNECESSARY PROCEDURES – REPORT OF TWO CASES
|
Bilic, Ivan |
|
2015 |
24 |
S3 |
p. S54- 1 p. |
article |
166 |
PR153 VITAMIN D IMPORTANCE IN THE ONCOLOGY CONSULTATION FOR THE BREAST CANCER PATIENT
|
Fonseca, Vasco |
|
2015 |
24 |
S3 |
p. S74- 1 p. |
article |
167 |
Sponsored satellite symposia
|
|
|
2015 |
24 |
S3 |
p. S14-S15 2 p. |
article |
168 |
Sponsors (as of September 2015)
|
|
|
2015 |
24 |
S3 |
p. S5- 1 p. |
article |
169 |
Welcome
|
Cardoso, Fatima |
|
2015 |
24 |
S3 |
p. S1- 1 p. |
article |